Retail sale of pharmaceutical products
A&A INVESTMENTS AS
Revenue 2025
NOK 60,000
Operating profit
NOK 44,000
Equity
NOK 554,000
Incorporated
2023
Share capital
NOK 30,000
Key figures · 2025
Current ratio
2.23
Equity ratio
81.7%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 73.4% | |
| Net margin (%%) | 53.7% | |
| Return on assets (%%) | 6.5% | |
| Likviditet | ||
| Current ratio | 2.23 | |
| Working capital | 152k | |
| Soliditet | ||
| Equity ratio (%%) | 81.7% | |
| Debt-to-equity ratio | 0.22 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.